Fundraising Fox
EVOQ Therapeutics
3 known investors
Find your way into EVOQ Therapeutics
Sign up to see every warm intro you have to EVOQ Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the EVOQ Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EVOQ Therapeutics develops immunotherapies targeting autoimmune diseases by using proprietary NanoDisc technology to restore immune tolerance. The company focuses on treating conditions like Type 1 Diabetes, Multiple Sclerosis, and Lupus through novel therapeutic approaches.
Investors · 3
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $761.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $287.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does EVOQ Therapeutics do?
- EVOQ Therapeutics develops immunotherapies targeting autoimmune diseases by using proprietary NanoDisc technology to restore immune tolerance. The company focuses on treating conditions like Type 1 Diabetes, Multiple Sclerosis, and Lupus through novel therapeutic approaches.
- Who are EVOQ Therapeutics's investors?
- EVOQ Therapeutics's investors include ID Ventures, Invest Michigan, Michigan Rise.